SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-216532
Filing Date
2022-08-10
Accepted
2022-08-09 21:39:03
Documents
15
Period of Report
2022-08-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d376155d8k.htm   iXBRL 8-K 34798
2 EX-1.1 d376155dex11.htm EX-1.1 184013
3 EX-5.1 d376155dex51.htm EX-5.1 7650
7 GRAPHIC g376155snap1.jpg GRAPHIC 8443
  Complete submission text file 0001193125-22-216532.txt   417738

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mirm-20220809.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20220809_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20220809_pre.xml EX-101.PRE 11708
9 EXTRACTED XBRL INSTANCE DOCUMENT d376155d8k_htm.xml XML 3472
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 221150202
SIC: 2834 Pharmaceutical Preparations